Roche Buying Seragon In US For Up To $1.7 Billion

Now watching

Next video starts in : 7 Play

Roche Buying Seragon In US For Up To $1.7 Billion

Roche Buying Seragon In US For Up To $1.7 Billion
Replay video
Up next

AirAsia Plane Carrying 162 Lost; 3rd Malaysia Airline Shock

Unlock your personal NFL Now stream by signing in to NFL.com

Roche Buying Seragon In US For Up To $1.7 Billion

by Wochit 0:38 mins

Roche Buying Seragon In US For Up To $1.7 Billion

by Wochit 0:38 mins

Roche Holding AG says its U.S.-based biotech company Genentech has agreed to acquire American biotechnology firm Seragon Pharmaceuticals, Inc. for up to $1.725 billion in cash and contingency payments. The Basel, Switzerland-based pharmaceutical giant, which is the world's biggest manufacturer of cancer drugs, says the deal will give Genentech rights to Seragon's portfolio of oral drugs under development to treat certain kinds of breast cancer.

Wochit

Community

  1. 27:26

    Community Episode 1: Ladders

  2. 27:26

    Community Episode 2: Lawnmower Maintenance and Postnatal Care

  3. 24:40

    Community Episode 3: Basic Crisis Room Decorum

  4. 30:58

    Community Episode 4: Queer Studies and Advanced Waxing

  5. 0:29

    Watch a Sneak Peek of Community Episode 5

  6. 2:01

    Sin City Saints: Official Trailer

Yahoo Studios

  1. 1:28

    Indianapolis reacts to Governor Pence's "Religious Freedom" push

  2. 1:28

    Indianapolis reacts to Governor Pence's "Religious Freedom" push

  3. 12:19

    Wall Street's April Fools; Go Daddy's IPO; Walmart's political stand

  4. 2:18

    Walmart's bold stand on Arkansas' religious freedom bill

  5. 1:46

    Amazon releases Dash button

  6. 1:55

    Walmart pressures suppliers to lower prices: Report